Skip to main content
. 2018 Sep 4;2018(9):CD013102. doi: 10.1002/14651858.CD013102

Chisholm 2002.

Methods Randomised trial
Participants 26 participants with renal transplants (intervention 14; control 12)
Tertiary teaching hospital clinics
USA
Year of study: Not stated.
Interventions Intervention patients received input from a clinical pharmacist including medication review focused on controlling blood pressure, and (potential/actual) medication‐related problems. Recommendations for change communicated to nephrologists. For patients more than 8 months post‐transplant, there were pharmacist‐led monthly telephone follow‐ups.
Duration 12 months
Outcomes Systolic Blood Pressure, compliance rate
Notes Funding source: Carlos and Marguerite Mason Trust
Conflict of interest: Not stated
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Unclear. No description, although "prospectively randomised" was stated
Allocation concealment (selection bias) Unclear risk No description
Blinding of participants and personnel (performance bias) 
 All Outcomes/Outcome 1 Low risk Unblinded, but with objective outcomes
Blinding of outcome assessment (detection bias) 
 All Outcomes/Outcome 1 Low risk The clinic nurse was blinded as to which patients were in the intervention or control group
Incomplete outcome data (attrition bias) 
 All outcomes Low risk 3 dropouts. Between group attrition < 10%.
Selective reporting (reporting bias) Low risk Main results reported
Other bias Low risk None